Quiver Bioscience
PrivateLast Round
Grant
May 5, 2026
Total Funding Raised
$3.65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Quiver Bioscience is a biotechnology company that offers a neuroscience research platform to accelerate the discovery of therapeutics for central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quiver Bioscience Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Quiver Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2026 | ||||
| Strategic | Apr 13, 2026 | ||||
| Grant | Sep 18, 2025 | ||||
| Grant | Jul 2, 2025 | ||||
| Grant | Jul 1, 2025 | ||||
Grant | Mar 19, 2025 |
Key People
Founding team and executive leadership
Quiver Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| CURE Epilepsy | Grant |
| NIH Helping to End Addiction Long-term (HEAL) Initiative | Grant |
| NIH RADx | Grant |
| FRAXA Research Foundation | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| Exponential Capital Management | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 58% MoM.
- May 5, 2026
$9.3M grant from National Institute of Neurological Disorders and Stroke and NIH HEAL Initiative.
Quiver Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quiver Bioscience's valuation, stock price, and market status.